The biological effectiveness of proton beams varies with depth, spot size and lateral distance from the beam central axis. The aim of this work is to incorporate proton relative biological effectiveness (RBE) and equivalent uniform dose (EUD) considerations into comparisons of broad beam and highly modulated proton minibeams. A Monte Carlo model of a small animal proton beamline is presented. Dose and variable RBE is calculated on a per-voxel basis for a range of energies . For an open beam, the RBE values at the beam entrance ranged from 1.02-1.04, at the Bragg peak (BP) from 1.3 to 1.6, and at the distal end of the BP from 1.4 to 2.0. For a 50 MeV proton beam, a minibeam collimator designed to produce uniform dose at the depth of the BP peak, had minimal impact on the open beam RBE values at depth. RBE changes were observed near the surface when the collimator was placed flush with the irradiated object, due to a higher neutron contribution derived from proton interactions with the collimator. For proton minibeams, the relative mean RBE weighted entrance dose (RWD) was ~25% lower than the physical mean dose. A strong dependency of the EUD with fraction size was observed. For 20 Gy fractions, the EUD varied widely depending on the radiosensitivity of the cells. For radiosensitive cells, the difference was up to ~50% in mean dose and ~40% in mean RWD and the EUD trended towards the valley dose rather than the mean dose. For comparative studies of uniform dose with spatially fractionated proton minibeams, EUD derived from a per-voxel RWD distribution is recommended for biological assessments of reproductive cell survival and related endpoints. A 2003 MOSFET dosimetry for microbeam radiation therapy at the European Synchrotron Radiation Facility Medical physics 30 583-9 Brenner D J 2008 The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction Semin Radiat Oncol 18 234-9 Brown J M, Carlson D J and Brenner D J 2014 The Tumor Radiobiology of SRS and SBRT: Are More Than the 5 Rs Involved? Int J Radiat Oncol 88 254-62 Carabe-Fernandez A, Dale R G, Hopewell J W, Jones B and Paganetti H 2010 Fractionation effects in particle radiotherapy: implications for hypo-fractionation regimes Physics in medicine and biology 55 5685-700 Carabe-Fernandez A, Dale R G and Jones B 2007 The incorporation of the concept of minimum RBE (RbEmin) into the linear-quadratic model and the potential for improved radiobiological analysis of high-LET treatments International journal of radiation biology 83 27-39 Carlson D J, Stewart R D, Semenenko V A and Sandison G A 2008 Combined use of Monte Carlo DNA damage Simulations and deterministic repair models to examine putative mechanisms of cell killing Radiation research 169 447-59
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Introduction
Synchrotron-generated spatially fractionated microbeams have been reported to result in extraordinary normal tissue sparing (Dilmanian et al., 2002; Dilmanian et al., 2001; Dilmanian et al., 2003; Dilmanian et al., 2007; Bouchet et al., 2013; Bouchet et al., 2010; Serduc et al., 2008) . The idea of utilizing microbeams is based on the pioneering work by Zeman and Curtis (Zeman et al., 1961; Zeman et al., 1959) at Brookhaven National Laboratory who, while conducting cosmic-ray research, discovered an inverse relationship between radiosensitivity and tissue volume exposed in mouse brain irradiated with a deuteron beam. In the same lab three decades later, Slatkin et al. (Slatkin et al., 1992) proposed microbeam radiotherapy (MRT), as a way to spare normal tissue in thin plane-parallel synchrotron beams. The dimensions of the multi-planar arrays of X-ray beams are typically in the range of 20-100 µm full width at half maximum (FWHM) with a centre-to-centre (CTC) spacing of about 100-400 µm and dose rates up to the order of 10 4 Gy/s. More recently it has been reported by Dilmanian et al. (Dilmanian et al., 2006) that wider beams up to 680 µm width retain a normal tissue sparing effect, which has prompted research into alternative approaches to synchrotron-generated beams.
Investigators at the Institute of Cancer Research in Sutton, UK (Bartzsch et al., 2016) proposed an MRT approach based on a conventional X-ray tube with microbeam dimensions of 50 µm beam width and 400 µm CTC spacing. Wider, but still submillimetre beams, are termed minibeams. Examples of X-ray based minibeam systems include the carbon nanotube based 160 kVp system at the University of North Carolina (Zhang et al., 2014b) with a beam width of 280 µm. Proton based minibeam systems include the 100 MeV beam by the group in Orsay, France (Prezado and Fois, 2013; Peucelle et al., 2015; Guardiola et al., 2017) , who demonstrated the first experimental implementation in 2014; the 20 MeV ion microprobe SNAKE by investigators in Munich (Girst et al., 2015a; Girst et al., 2016; Girst et al., 2015b; Zlobinskaya et al., 2013) who used a grid of submillimetre pencil beams, termed microchannels; and the work conducted in collaboration between Brookhaven National Laboratory and MD Anderson Cancer Center (Dilmanian et al., 2015b; Dilmanian et al., 2015a) , who investigated a 109 MeV beam with 300 µm width and 1 mm CTC spacing. We have recently presented a feasibility study for a 50.5 MeV proton minibeam (Lee et al., 2016a; Lee et al., 2016b) based on our image-guided precision proton radiation platform (PPRP) for preclinical in vivo research at the University of Washington (Ford et al., 2017) . The multi-slit collimator was designed to produce a uniform dose at the depth of the Bragg Peak (BP), while retaining high modulation on the entrance side. The collimator dimensions are comparable to the above systems with 1 mm CTC spacing and 300 µm slit width. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t
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To explore the expected biological response to this type of irradiation, and before biological experiments are conducted, exact knowledge of both the physical and biologically effective dose is crucial. It is often implicitly assumed that the RBE of low energy X-rays, as is used for synchrotron-generated microbeams, is close to unity even though a number of published studies (Nikjoo and Lindborg, 2010; Botchway et al., 1997; Fayard et al., 2002; Hoshi et al., 1988; de Lara et al., 2001; Cornforth et al., 1989; Spadinger and Palcic, 1992) indicate lower energy (< 100-200 kV) X-rays are more biologically damaging per unit absorbed dose than 60 Co -rays or MV X-rays. As an example, the RBE for DNA double strand break induction (RBEDSB) for a 60 kV X-ray beam (no filtration except 0.8 mm Beryllium exit window) is ~1.3 (Stewart et al., 2015) . It is important to note also that there is a strong correlation between RBEDSB and the RBE for cell survival as demonstrated recently by Streitmatter et al. (Streitmatter et al., 2017) . Those investigators demonstrated that the two RBE values were within a few percent of each other for electrons and photons with energies in the range from about 250 eV to 1
MeV. Synchrotron-generated X-ray microbeams experiments have been reported to use median energies as low as 50-70 keV (Laissue et al., 1998; Dilmanian et al., 2002) .
For clinical proton beams, Monte Carlo simulations suggest that RBEDSB may be as large as 1.2 to 1.3 near the apogee of the BP (Stewart et al., 2015) . A significant difference from the purported constant (spatially invariant) RBE value of 1.1 in common clinical use (Chaudhary et al., 2014) . Distal to the BP, Monte Carlo simulations (Stewart et al., 2015) suggest that RBEDSB may increase further to values as high as 1.6 to 1.8, although only over a small distance very close to the proton range where proton fluence is relatively small compared to that incident. Increased scatter in the penumbra regions and in very small fields can also lead to higher RBE values due to energy spectrum changes (Stewart et al., 2015; Schmid et al., 2012) . This is particularly relevant for very narrowly collimated, highly modulated proton beams, as path length straggling is more dominant in penumbra regions leading to lower energy protons that result in higher RBE values. Therefore, a meaningful comparison between different particle type and energy beams is only possible when RBE-weighted dose (RWD) is considered. To facilitate such comparisons, knowledge of the beam energy fluence per particle per voxel is necessary, which itself requires detailed information on the proton and secondary particle energy spectrum within the voxel.
Another factor that has complicated the comparison of experimental results derived from beams of different energy beams and/or collimator geometries is the lack of a generally accepted dose prescription and reporting Page 4 of 33 AUTHOR SUBMITTED MANUSCRIPT -PMB-106214. R1   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t 5/33 formalism for spatially fractionated beams. For synchrotron-based spatially modulated research, the peak and valley doses as well as the peak-to-valley dose ratio (PVDR) are generally used dose parameters. For comparison with uniform beams, the dose is often specified on the beam entrance side using either Monte Carlo simulations and/or physical dosimetry approaches (Siegbahn et al., 2006; Ptaszkiewicz et al., 2008; Brauer-Krisch et al., 2003; Kaplan et al., 2000; Brauer-Krisch et al., 2015) , the latter approach being subject to relatively large measurement uncertainties (Crosbie et al., 2008) . More recently, prescription attempts have been made that use absorbed dose values averaged over a lateral slice of material oriented perpendicular to the beam central axis for comparative studies of broad and micro-or mini-beams. For instance, Girst et al. used the mean skin dose to design an equipoised experiment to compare spatially fractionated proton pencil beams with a uniform proton beam. However, in some beam delivery cases, the Girst et al. prescription approach may not be fully appropriate. Our previous simulations of collimator-produced proton minibeams (Lee et al., 2016b) have shown that placement of a collimator relative to an irradiated object can have a considerable impact on the peak and valley doses as well as on the neutron contribution to the entrance dose (Lee et al., 2016a) . This impact was also independently verified by Guardiola et al (Guardiola et al., 2017) . So even if the mean physical dose between modulated and uniformly irradiated scenarios is equivalent, the RWD may not be biologically equivalent, especially when proton minibeams are compared to microbeams or broad beams of kV or MV Xrays.
Explicit considerations of variable RBE and spatial variations in physical dose must be taken into consideration when designing experiments to probe for new or refined biological mechanisms of action underlying the potential therapeutic advantages of micro-or mini-beam irradiation. In most publications related to micro-and minibeam experiments produced by collimation, it is not clear if the exact positioning and orientation of the collimator was carefully considered in the dosimetry or if beam spectral changes were considered with beam line positioning changes and possibly other components. Of note is one innovative experimental approach to determine the dose equivalence between microbeam irradiation and conventional broad beams. Ibahim et al. (Ibahim et al., 2014) used clonogenic and cell impedance assays, but highlighted that their dosimetry of the synchrotron beam was based on an idealized geometry and it was therefore likely that the valley dose was underestimated. Another approach was proposed by Zhang et al. for clinical X-Ray based grid therapy for melanoma on a linear accelerator (Zhang et al., 2014a) . They used the Linear-Quadratic (LQ) model and calculated the equivalent uniform dose (EUD). A c c e p t e d M a n u s c r i p t
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The aim of this work is to compare and contrast important dosimetric parameters (i.e., mean dose, valley and peak dose, EUD), with and without corrections for spatial variations in proton RBE (vRBE) and to establish the need to better account for RBE effects in prospective and retrospective analyses of the biological effectiveness of spatially fractionated beams. This work is based on Monte Carlo simulations of physical dose, linear energy transfer (LET) and RWD using a published Monte Carlo model for DSB induction (Stewart et al., 2011; Stewart et al., 2015) as implemented in TOPAS, a Tool for Particle Simulations with Monte Carlo (Polster et al., 2015; Perl et al., 2012) . As discussed elsewhere (Paganetti, 2014) , there is considerable uncertainty in determinations of dose-averaged LET and the RBE for various biological endpoints. However, the use of published biophysical models provides a reproducible and plausible framework to explore the potential significance of differences in physical dose and RWD as it relates to micro-and mini-beams of photons and protons in comparison to broad beams of the same or different types of radiation. To our knowledge, variable RBE considerations have not been applied to proton minibeam dosimetry. We also explore the applicability of the EUD concept for these beams with and without the inclusion of the RWD and for low and high fraction doses relative to the  ratio, to determine a formalism that better enables comparisons of spatially fractionated and uniform beams based on DSB induction and the LQ model for cell survival.
Methods
The University of Washington (UW) research proton beam line was modelled by means of Monte Carlo (MC) simulations in TOPAS (Perl et al., 2012) , version 3.0.p1. Compared to previous work by our group (Lee et al., 2016b; Ford et al., 2017) , modifications have been made to the proton beamline to integrate it with the isocenter of a Small Animal Radiation Research Platform (SARRP) (XStrahl Ltd, Surrey, UK). The changes affected the beam characteristics and therefore several components had to be added or moved when depicted in the simulations. The UW cyclotron produces a 50.5 MeV monoenergetic proton beam before it enters the research beamline. The components modelled in the beamline include 1) a 1.23 mm thick graphite beam degrader upstream, 2) a "large" stainless steel beam pipe, 3) a graphite/stainless steel stray beam detector that connects the large beam pipe with 4) a smaller stainless-steel beam pipe with inner diameter 35 mm including 5) a 0.15 mm thick Kapton exit window to contain the vacuum and 6) a protruding small beam pipe downstream of the
Kapton that is open to air. Between the beam exit window and a water phantom with a 1 mm Lexan entrance window is a large Bragg peak ionization chamber (Model T34080, PTW, Freiburg, Germany), henceforth A c c e p t e d M a n u s c r i p t 7/33 referred to as the monitoring ion chamber. The monitoring ion chamber is necessary to trigger and terminate the beam. A multi-slit minibeam collimator can be placed between the monitoring ion chamber and the water phantom. A schematic of the beamline from the stray beam detector to the water phantom, but without the monitoring chamber, can be found in Lee et al. as Figure 1 (Lee et al., 2016b) . A prototype multi-slit collimator was made from 25 mm thick SAE 304 steel. It contained thirty-one 300 µm wide slits with a CTC spacing of 1 mm covering a field size of 3x3cm. The multi-slit collimator was designed to produce a uniform dose at the depth of the BP via post collimator scattering in water while retaining the produced high spatial modulation at shallow depths in the water.
The exact positioning of the monitoring ion chamber and the water phantom was modelled in TOPAS.
Simulations were run using 10 9 proton particle histories. The TOPAS simulations were run on two processors (Intel(R) Xeon(R) CPU E5-2697 v3 @ 2.60GHz, with 14 cores each, 256 GB RAM). The voxel dimension along the beam axis for simulation computations were 0.05 mm, and 0.8 mm and 0.05 mm along and across the direction of the modulation of the beam, respectively. Binary output files were generated and imported into MATLAB (MathWorks, Natick, MA, USA) for further analysis.
Physical dose
To investigate and verify the beam energy, the first step was to validate the modified beamline model in TOPAS without the multi-slit collimator in place. Modelling the beam energy correctly is the basis for accurate modelling of the LET and RBE. Percentage depth dose (PDD) measurements were conducted with an Exradin Spokas A11 parallel plate ion chamber with a collecting volume of 0.62 cc (Standard Imaging, Middleton, WI, USA) and a microDiamond detector (Type 60019, PTW-Freiburg, Germany) with a nominal sensitive volume of 0.004 mm³. The A11 ion chamber was manually positioned along the central axis by means of a micrometre motion stage in 100 µm steps around the BP and 1 mm in steps in the build-up region. The microDiamond detector was positioned by means of a motion stage (Saini et al., 2017) every 500 µm.
LET-and RWD for the endpoint of DSB Induction
The dose-averaged LET, averaged over all protons and secondary particles, was calculated by TOPAS on a pervoxel basis. Dose-averaged LET is slightly larger than the track-averaged LET (Granville and Sawakuchi, 2015; Guan et al., 2015) . The RBEDSB within the voxel was simulated using information from the Monte Carlo Page 7 of 33 AUTHOR SUBMITTED MANUSCRIPT -PMB-106214. R1   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t
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Damage Simulation (MCDS) (Stewart et al., 2015; Stewart et al., 2011) as implemented in TOPAS (Polster et al., 2015) . Estimates of RBEDSB, which have been extensively benchmarked against measured data and track structure simulations (Stewart et al., 2011; Streitmatter et al., 2017) , are based on 60 Co -rays as reference radiation (Stewart et al., 2015) . For electrons and photons, RBEDSB is within a few percent of the RBE for reproductive cell survival (Streitmatter et al., 2017) . For Z > 1 particles, the repair-misrepair-fixation (RMF) model (Carlson et al., 2008) predicts that the RBE for cell survival will be greater than or equal to RBEDSB.
Thus, the RBEDSB values presented in this work represent the lower bound on the RBE for cell survival for comparison to a constant RBE of 1.1. The RWD was computed on a per-voxel basis for both the open and spatially modulated beams with the collimator placed at different distances from the water phantom.
Calculation of Equivalent Uniform Dose
The equivalent uniform dose is defined as "the uniform dose that, if delivered over the same number of fractions as the non-uniform dose distribution of interest, yields the same radiobiological effect" (AAPM Task Group 166, 2012). The EUD (Niemierko, 1997) was applied to evaluate and compare uniform with non-uniform irradiation geometries. For the endpoint of cell survival, the EUD is given by
and are parameters in the LQ cell survival model, ̅ is the surviving fraction (SF), is the volume of a single voxel, = ∑ is the total volume of the region of interest (ROI), and the number of voxels in the ROI. In this work, the concept of EUD is explored with both the physical dose, D, and the RBE-weighted dose, RWD (instead of D). is the 60 Co γ-ray absorbed dose delivered to the i th voxel that creates the same number of DSB per cell as proton absorbed dose × . For the special case when = = / , the surviving fraction averaged over all n voxels computed using RWD is
For the special ("low dose") scenario when ≪ ( ⁄ ), .
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For the sake of this comparison, we do not distinguish between tumour cells and normal tissues per se but investigate the concept more generally for a representative range of  ratios (1 and 10 Gy). To bracket the range of radiosensitive to radioresistant tissues, we assume surviving fractions between 0.1 and 0.95, respectively, after uniform irradiation by a 2 Gy proton dose at the BP. The EUD formalism was calculated in MATLAB and applied to the imported physical and dose-averaged RBE from TOPAS. Both the mean doses and the EUD were computed along the central axis (CAX) across each 0.05 mm voxel layer within the 3×3 cm field size. For comparison, we also computed RBEDSB for a range of energies on our beamline (without multi-slit collimator) to examine the energy dependence and magnitude of the RBEDSB over the range of available energies at other proton minibeam facilities. The results are given in The RBE effects on the dose profiles are shown in Figure 5 . The PDDs through the central peak and valley for the collimated beam are shown in Figure 6 . A comparison of the mean dose and EUD range for different  ratios and surviving fractions is also shown for two scenarios. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t 11/33 are similar to Figures 6c and 6d , respectively, except that the dose was normalized to 20 Gy, to highlight its impact on the EUD.
Results

Discussion
Determining the biologically equivalent dose deposited by a polyenergetic proton beam requires exact knowledge of the beam's spectrum as a function of spatial location in the absorbing medium. To gain this knowledge, we developed a Monte Carlo simulation model of the University of Washington PPRP beamline including all of its pertinent components. The beam energy of this model was verified by means of PDD measurements ( Figure 3 ) and a comprehensive analysis was carried out with respect to the influence of the most relevant components of the beam spectrum (Figure 1 and 2a) . Although the beam is degraded by about 5 MeV along the beam path, to a peak energy of 45 MeV, the initially monoenergetic proton beam remains mostly pristine with only a small energy spread of ±0.5 MeV. This is important as the sharpness of the BP is greatest for a monoenergetic beam and deteriorates when the proton energy spectrum broadens. To generate spatially modulated beams, the beam spot can either be scanned (Klodowska et al., 2015) or generated by a multi-slit collimator (Lee et al., 2016b) . The effects of a multi-slit collimator for proton minibeams at different distances from a phantom were modelled and the results are shown in Figure 2 . The collimator does not further degrade the proton energies within the beam; rather, it results in a slight narrowing of the 45 MeV peak and reduces the tail of scattered energies between 35 and 42 MeV regardless of its position relative to the phantom. However, the neutron contribution increased when the collimator was introduced, especially when the collimator was placed flush with the phantom surface, leading to an increase by approximately a factor of 8 ( Figure 2b) .
Overall, the neutron contribution is very small, less than 1% of the proton counts, but due to the higher RBE of neutrons, and subsequently higher RWD, the relative biologically relevant dose contribution is higher. The neutron contribution at the phantom surface reduces sharply as a function of distance of the collimator from the phantom surface and is almost equivalent to that of a non-collimated beam when placed 5 cm distant from the surface. These observations are in line with our previous findings (Lee et al., 2016a) and those independently made by Guardiola et al. (Guardiola et al., 2017) . Thus, to decrease the number of neutrons on the surface, the collimator should be placed away from the entrance. Unfortunately, this also will decrease the collimator's effective degree of spatial modulation, i.e. the PVDR. For the current collimator simulations, the PVDR at the entrance was 37 when the collimator was placed flush (Figure 6a ) and reduced by a factor of 10 to 3.7 at 2 cm distant from the surface (Figure 6c ). This further highlights the strong dependency of the dosimetry of these 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t 12/33 spatially modulated proton beams on the position of the collimator relative to the irradiated object, as previously described (Lee et al., 2016b; Guardiola et al., 2017) .
RBE considerations
Although DSB are widely considered one of the more biologically challenging forms of DNA damage to repair, the majority (> 95-97%) of the initial DSB formed by ionizing radiation are correctly rejoined. The Repair-Misrepair-Fixation (RMF) model (Mairani et al., 2016; Carlson et al., 2008; Frese et al., 2012; Streitmatter et al., 2017) 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t 13/33 comparing results generated by different beamlines. The values show that, as expected, both LET and RBEDSB decrease with increasing beam energy. However, for the 50.5 MeV beam and higher energies, the RBEDSB at 1 mm depth is nearly identical (1.03 ± 0.01); the same is true at the BP, where the RBE is 1.33 ± 0.08. The RBEDSB towards the distal end of the BP shows higher variation, but due to the lower physical dose delivered, this typically has less of an impact. For lower energies, the RBEDSB increases more drastically. Overall, the RBEDSB values between the surface and depth of the BP are, while continuously changing, comparable for nominal energies between 50-109 MeV. For lower energy beams not included here, higher LET and RBEDSB values are expected.
For the UW 50.5 MeV beam, both LET and RBEDSB follow a similar trend with noisier values towards the distal end of the BP (Figure 4) . The RWD is close in value to the relative physical dose between the surface and the proximal side of the BP. The steep near-linear increase in RBEDSB starts at about 1 mm before and ends 1 mm after the BP. For clinical beams at higher energies, a constant RBE of 1.1, referred to as cRBE, is typically used.
It is shown in Figure 4 that along the CAX a constant RBE of 1.1 overestimates RBEDSB by approximately 5% down to a depth of 12 mm, then the two are about equal for a few mm before RBEDSB increases sharply. The near-linear trend in the LET and RBEDSB towards the end of the beam is not reflected in the RWD difference between the vRWD and the cRWD (Figure 4d ). Effectively the largest RWD difference is past the BP at a depth of 17.15 mm and tapers off to either side. Table 2 shows that placing a collimator in the beam path does not substantially affect the LET and RBEDSB values at the BP. The effects of the RWD for a modulated beam generated with a steel collimator are shown in Figures 5 and 6. Note that Figure 5 is normalized to the CAX at 1 mm depth and Figure 6 to the CAX at the depth of the BP. At shallow depths, the valleys and peaks are about 5% lower than the constant RBE value of 1.1 that is commonly clinically assumed (Figure 5c and 5g ). While this does not affect the PVDR considerably, it does lead to lower valley doses, which have been reported to correspond to the normal tissue tolerance of uniformly irradiated beams (Siegbahn et al., 2006) . At a depth around the BP, the higher RWD result in higher peak doses by a factor of 43% at the BP (Figures 5d and h) . When the RWD is normalized to the BP, as was done for Figure 6 , the relative entrance valley doses are therefore reduced. Also of note are the increased RBEDSB values in the penumbra regions resulting in an increased RWD. This can be seen in Figures 5c-d and 5g-h. While the physical dose between the collimator placed flush with the phantom (Figure 5a-b) 
EUD considerations
Zeman and Curtis (Zeman et al., 1961; Zeman et al., 1959) to (Brown et al., 2014; Kirkpatrick et al., 2008; Brenner, 2008) . It has also recently been reported that the LQ model may not be adequate to predict the response for spatially fractionated fields as it does not sufficiently account for bystander effects (Peng et al., 2017) . Consequently, the above plus other unknown biological processes that possibly contribute to the overall response of the cells within or near a tissue region of interest may not be captured by EUD when radiation response is elicited by highly spatially fractionated beams. With this in mind, when comparing uniform with spatially fractionated dose distributions it is therefore imperative to compute the EUD to be able to separate known from unknown factors. For synchrotron based microbeam radiotherapy, decreased radiosensitivity effects have commonly been referred to as the "normal tissue sparing effect" (Dilmanian et al., 2007) .
To investigate the influence of the EUD on different sensitivity cells and as a function of dose (c.f. Eq. 1 & 2), the EUD was calculated for 2 Gy and 20 Gy at the BP for a range of surviving fractions (0.1 to 0.95) and
ratios (1 and 10 Gy) for the UW proton mini beam. This EUD dependency is shown together with the mean Page 14 of 33 AUTHOR SUBMITTED MANUSCRIPT -PMB-106214. R1   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t 15/33 dose in the plot of the PDDs in the peak and valley regions in Figure 6 . Figure 6c-d show that the EUD is close to the mean physical dose and the mean RWD but not identical when the collimator is 2 cm distant. The larger difference is seen for the collimator placed flush (Figure 6a-b) . While the overall difference between the mean dose and EUD is indistinguishable in the BP region, the difference is most obvious on the beam entrance side down to about 10 mm depth. The higher neutron contribution with the collimator placed flush (Figure 2a) is the main contributing factor for this observation. Therefore, the BP dose is relatively uniform and the physical dose, the EUD and mean dose are very similar per their definition. For the higher  ratios, the EUD tends to be lower than the mean dose, whereas for the lower ratios the EUD tends to be higher. In terms of the peak and valley doses, the difference in the shape of the PDDs between the different collimator positions is substantial. In Fig. 6c-d , the relative peak dose along the collimator slit is much lower and remains nearly constant with depth down to the proximal end of the BP, whereas the relative valley dose increases somewhat. Despite the differences in the PVDR between the collimator placed flush and 2 cm distant, the mean dose and the mean RWD are nearly identical as pointed out above. Increasing the dose to 20 Gy thus does not affect the relative mean dose. However, since the EUD is dependent on dose, large deviations between the EUD and the mean dose can occur. For larger doses, the EUD tends towards the valley dose, especially for the radiosensitive cells (SF= 0.1) regardless of ratio. It can be clearly seen that for large doses the mean dose and mean RWD overestimate the EUD. Therefore, the mean dose and mean RWD are not adequate metrics to compare uniform and non-uniform proton beams for the endpoint of reproductive cell survival.
This work primarily investigates proton minibeams but is also relevant more generally for X-Ray based spatially modulated microbeams for which cell and small animal data are available. For example, early small animal experiments that reported extraordinary normal tissue sparing and a greater therapeutic index of modulated synchrotron microbeams used median X-ray energies in the range 50-70 keV (Laissue et al., 1998; Dilmanian et al., 2002) with peak skin entrance doses as high as 500 Gy. RBE and EUD considerations would most likely affect the reported results, such as e.g. a reported gain in therapeutic index of a factor of ~5 (Dilmanian et al., 2002) for microbeam therapy over uniform irradiation. This is not to say that bystander effects have no additional significance for modulated beams, which in fact has been demonstrated consistently. On the contrary, accounting for the biological dose equivalence of modulated and uniformly irradiated beams enables better experimental design and reporting of the aforementioned effects. The experimental verification of the models and considerations presented in this work should be the next step and remains an area of further work. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t 16/33
Conclusion
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Page 24 of 33 AUTHOR SUBMITTED MANUSCRIPT -PMB-106214. R1   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 A c c e p t e d M a n u s c r i p t 25/33 Fig. 2 : Proton (black) and neutron (green) energy spectra at entrance of water phantom with a) no collimator, b) collimator placed flush at water phantom, c) collimator placed at 2 cm distance and d) collimator placed at 5 cm distance from the water phantom. Left axis shows relative neutron counts and right axis relative proton counts. Note that the proton counts for the open beam in a), corresponding to p+ after monitoring ion chamber in Fig. 1 , are truncated to be on the same scale as the collimated beam ( Figs. 2b-d ).
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